Hosted on MSN
Oxide reduces potential dilution as 3rd-series stock options expire and are partially exercised
OXIDE Corp. ( (JP:6521)) has provided an announcement. OXIDE Corporation reported the December 2025 exercise status of its 3rd series stock acquisition rights, with 7,000 shares delivered through the ...
MELBOURNE, Australia and NEW YORK, May 28, 2025 (GLOBE NEWSWIRE) -- Incannex Healthcare Inc. (Nasdaq: IXHL), a clinical-stage biopharmaceutical company advancing combination drug therapies for ...
Incannex Healthcare cancels 172 million Series A Warrants, reducing potential share dilution and strengthening capital structure ahead of key trial data. Incannex is eliminating up to 347.2 million ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results